Hyperliquid Strategies — a Nasdaq-listed company that’s basically a HYPE buying bot with a corporate shell — just jacked its equity-dilution facility with Chardan from $1B to $2.5B. They’ve already raised at least $763.7M by printing shares and dumping them on Chardan to stack HYPE. Cute, but the real cap is way smaller than the headline screams.
▪️ They sold $646.6M in equity by June 30, then another $117.1M after that — that’s $763.7M raised, leaving ~$236.3M before the $1B trigger.
▪️ Once aggregate sales cross $1B, a new price floor kicks in: they can’t issue more shares below $12.02 if it would push the count above 42,641,847 shares (19.99% of voting power).
▪️ Shares sold at $12.02+ don’t count toward that cap. But the filings don’t give trade-level prices, so the true headroom is a mystery — even to you.
▪️ So far they’ve deployed $773.4M into ~16.5M HYPE and hold ~29.3M total. That’s a lot of bags they’re banking on.
▪️ The $2.5B is ‘optional financing capacity’ — not a buy order. Once they hit $1B in gross sales, the rest depends on price, cap headroom, and maybe a shareholder vote.
📊 Facility limit:
$2.5B📊 Original limit:
$1B📊 Raised so far:
$763.7M📊 Left before $1B trigger:
~$236.3MFor retail, this is a transparency black hole. They’re selling equity to buy a token you might be holding — and the dilution mechanism is opaque past $1B. If HYPE dips, the equity sales could accelerate to raise cash, dumping shares on Chardan who dumps them on the market. You’re not just betting on HYPE price; you’re betting that the treasury manager doesn’t get squeezed. Good luck reading those filings.
💬 «The $2.5 billion facility therefore represents optional financing capacity, not a guaranteed HYPE buying program.» — CryptoSlate report
🔮 They’ve already raised 76% of the first $1B, but the next $1.5B is a mirage unless HYPE stays above $12. Check the price floor logic.
@exverse_chat
